Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Axcan (Photofrin and Photobarr)

M&A STATUS
Asset Purch. LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

A novel therapeutic technique approved for the treatment of non-small cell lung cancer (NSCLC) and esophageal cancer.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Primary Office
  • 597 boulevard Laurier
  • Mont-Saint-Hilaire, Quebec J3H 6C4
  • Canada

Axcan (Photofrin and Photobarr) Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Axcan (Photofrin and Photobarr)‘s full profile, request access.

Request full access to PitchBook

Axcan (Photofrin and Photobarr) Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Axcan (Photofrin and Photobarr)‘s full profile, request access.

Request full access to PitchBook